# Photodynamic Therapy for COVID-19 Prevention

> **NCT05184205** · NA · COMPLETED · sponsor: **Ondine Biomedical Inc.** · enrollment: 100 (actual)

## Conditions studied

- COVID-19 Respiratory Infection
- SARS-CoV-2 Acute Respiratory Disease

## Interventions

- **DEVICE:** Nasal Photodisinfection
- **DEVICE:** Sham Comparator: Control

## Key facts

- **NCT ID:** NCT05184205
- **Lead sponsor:** Ondine Biomedical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-20
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05184205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05184205, "Photodynamic Therapy for COVID-19 Prevention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05184205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*